Viewing nowCombinationPosimet Extended Release Tablet 10/1000 mg
Dapagliflozin citric acid 14.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Withers Pharmaceuticals Co., Ltd.

MFDS item code 202107048 · Approved 2021.10.20 · Insurance code 660703750
Improvement of blood glucose control in adults with type 2 diabetes mellitus
This medication assists in improving blood sugar control in adult patients with type 2 diabetes through the combined administration of dapagliflozin and metformin, in conjunction with dietary and exercise therapy. It is specifically used for patients with type 2 diabetes who have inadequate blood sugar control and have cardiovascular disease or risk factors. For additional information related to the occurrence of cardiovascular events, reference to clinical trial information for professionals may be helpful. This medication improves blood sugar control and aids in cardiovascular health management.
The dose of this medicine should be individualized based on the patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended doses of dapagliflozin 10mg and extended-release metformin 2000mg. This medicine is generally administered once daily with the evening meal. The maximum dose of this medicine is dapagliflozin 10mg/extended-release metformin 2000mg once daily, given as 2 tablets of 5mg/1000mg. Patients who have not previously received antidiabetic drug therapy and for whom monotherapy does not provide adequate glycemic control: When used as initial therapy in patients with no previous antidiabetic drug treatment, the recommended starting dose of this medicine is one tablet of 5mg/500mg or 10mg/500mg once daily. Titrate the dose gradually to reduce gastrointestinal adverse reactions associated with metformin. In patients receiving metformin, the recommended dose of dapagliflozin is 10mg once daily, and the dose of this medicine should provide the dose of metformin previously taken or an appropriately equivalent therapeutic dose. When switching from immediate-release metformin to the extended-release formulation, glycemic control should be closely monitored and the dose adjusted appropriately. In patients switching from combination therapy with dapagliflozin and metformin to this medicine, start this medicine at the doses of dapagliflozin and metformin previously administered. When switching from immediate-release metformin to the extended-release formulation, glycemic control should be closely monitored and the dose adjusted appropriately. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. The safety and efficacy of this medicine have not been specifically evaluated in patients switched to it from another antihyperglycemic agent. Because changes may result in altered glycemic control, any change in the treatment of patients with type 2 diabetes should be made under close monitoring. This medicine must be swallowed whole and must never be crushed, cut, or chewed. Occasionally, inactive ingredients in this medicine may be excreted in the stool as a soft, hydrated mass that resembles a tablet. Renal impairment No dose adjustment is required in patients with mild renal impairment. For patients with an estimated glomerular filtration rate (eGFR) of 45 mL/min/1.73 m2 or more and less than 60 mL/min/1.73 m2 who do not have other conditions that may increase the risk of lactic acidosis, the starting dose of metformin hydrochloride, a component of this medicine, is 500mg once daily, and the maximum daily dose is 1000mg. Administration of this medicine is not recommended in patients with an eGFR below 45 mL/min/1.73m2. If the estimated glomerular filtration rate (eGFR) falls below 45 mL/min/1.73m2, this medicine should be discontinued immediately. Renal function should be assessed every 3~6 months. Elderly patients Because metformin is excreted through the kidneys and renal function is likely to decline in elderly patients, this medicine should be used with caution as age increases (see Precautions for Use, 9. Administration to Elderly Patients).
This medication can very rarely cause severe lactic acidosis, and caution is needed especially in patients with poor kidney function or those with serious infections, dehydration, etc. When used in conjunction with other diabetes medications, there may be an increased risk of hypoglycemia, so blood sugar levels should be closely monitored. Patients with allergies to this medication's main ingredients or additives, severe kidney impairment, acute myocardial infarction, or heart failure should not use this medication. Before and after tests using iodinated contrast agents, this medication should be temporarily discontinued and confirmed that kidney function is normal before resuming use. In patients with low fluid volume or decreased kidney function, their condition should be well evaluated before administration, and blood pressure and kidney function should be continuously monitored during administration. This medication can affect blood sugar control, so when used with insulin or sulfonylureas, dose adjustments may be necessary to prevent hypoglycemia. During treatment, symptoms such as genital infections, urinary tract infections, hypoglycemia, and dehydration may occur, so if any unusual symptoms arise, immediate consultation with healthcare professionals is advised. Women who are pregnant or may become pregnant, or are breastfeeding, should not use this medication. Elderly patients or those with reduced kidney function should have their doses carefully adjusted, and regular kidney function tests are necessary. In case of overdose, immediate visit to a medical institution for appropriate treatment is required, and if necessary, dialysis may be performed to eliminate the drug. Moreover, excessive alcohol consumption should be avoided while taking this medication, and care should be taken when driving or operating machinery as dizziness may occur.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air and moisture ingress, and it is important to maintain a storage temperature between 1 to 30 degrees at room temperature. Proper storage will help maintain the medication's effectiveness longer.
Yellow, film-coated, bilaterally convex egg-shaped tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationDapagliflozin citric acid 14.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Withers Pharmaceuticals Co., Ltd.
CombinationDapagliflozin citric acid 14.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
CombinationDapagliflozin citric acid 7.35mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
Dapagliflozin citric acid 14.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Poonglim Pharmaceutical Co., Ltd.
Dapagliflozin citric acid 7.35mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Punglim Muhak Co., Ltd.
CombinationDapagliflozin citric acid 14.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Korea Prime Pharmaceutical Co., Ltd.
Dapagliflozin citric acid 7.35mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Korea Prime Pharmaceutical Co., Ltd.
CombinationDapagliflozin citric acid 14.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
KS Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.